AMENDED & RESTATED COLLABORATION AND LICENSE AGREEMENTCollaboration and License Agreement • November 14th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
This AMENDED & RESTATED COLLABORATION AND LICENSE AGREEMENT (“Agreement”) is entered into as of July 5, 2023 (the “Effective Date”) between VBI VACCINES INC., a company organized under the laws of the Province of British Columbia, Canada (“VBI”), and having a principal place of business at 310 Hunt Club Road, Suite 201, Ottawa ON K1V 1C1, and BRII BIOSCIENCES LIMITED, an exempted company organized under the laws of the Cayman Islands (“Brii Bio”), having its registered office at Vistra (Cayman) Limited, PO Box 3119, Grand Pavilion Hibiscus Way, 802 West Bay Road Grand Cayman KYI-1205.
ContractLoan and Guaranty Agreement • November 14th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
This letter agreement (as amended, restated, supplemented or otherwise modified from time to time, this “Letter Agreement”) confirms our understanding to further extend the due date to deliver the Compliance Certificate for the period ending September 30, 2023, from November 6, 2023, to November 13, 2023 (the “Extension Date”). Lenders agree that until the Extension Date the Lenders will refrain from declaring an Event of Default under the Loan Agreement and/or the other Loan Documents.
LETTER AGREEMENTLetter Agreement • November 14th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations • New York
This LETTER AGREEMENT (the “Agreement”) is entered into as of July 5, 2023 (the “Effective Date”) between VBI VACCINES INC., a company organized under the laws of the Province of British Columbia, Canada (“VBI”), VARIATION BIOTECHNOLOGIES INC., a Canadian federal corporation (“VBI CA”), SCIVAC LTD., an Israeli corporation and a subsidiary of VBI (“SciVac”), and BRII BIOSCIENCES LIMITED, an exempted company organized under the laws of the Cayman Islands (“Brii Bio” and together with VBI and SciVac, each a “Party” and together the “Parties”).
FORBEARANCE AGREEMENTForbearance Agreement • November 14th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
This FORBEARANCE AGREEMENT (this “Forbearance Agreement”) is entered into as of November 13, 2023 (“Effective Date”) by and among VARIATION BIOTECHNOLOGIES INC., a Canadian federal corporation (“Borrower Representative”), VBI VACCINES INC., a British Columbia corporation (“Parent”, and together with Borrower Representative, and any other Person from time to time party to the Agreement (as defined below) as a borrower, collectively, “Borrowers”, and each, a “Borrower”), each of the parties set forth on the signature page hereto as guarantors (together with any other Person from time to time party to the Agreement as a guarantor, collectively, “Guarantors” and each, a “Guarantor”), the lenders party hereto (together with any other lender from time to time under the Agreement, collectively, “Lenders”, and each, a “Lender”) constituting Required Lenders (as defined in the Agreement (as defined below)), and K2 HEALTHVENTURES LLC, as administrative agent for Lenders (in such capacity, togeth
ContractLoan and Guaranty Agreement • November 14th, 2023 • VBI Vaccines Inc/Bc • Pharmaceutical preparations
This letter agreement (as amended, restated, supplemented or otherwise modified from time to time, this “Letter Agreement”) confirms our understanding to extend the due date to deliver the Compliance Certificate for the period ending September 30, 2023, from October 30, 2023, to November 6, 2023 (the “Extension Date”). Lenders agree that until the Extension Date the Lenders will refrain from declaring an Event of Default under the Loan Agreement and/or the other Loan Documents.
